DrugPatentWatch Database Preview
Baxalta Incorporated Company Profile
Email this page to a colleague
» See Plans and PricingUS Patents for Baxalta Incorporated
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxalta Incorporated | FEIBA | anti-inhibitor coagulant complex | KIT | 101447 | 1 | 1986-01-31 | 9,643,998 | BAXALTA GMBH (Opfikon, CH) BAXALTA INCORPORATED (Bannockburn, IL) | 2030-12-16 | search | ||
| Baxalta Incorporated | FEIBA | anti-inhibitor coagulant complex | KIT | 101447 | 1 | 1986-01-31 | 9,447,401 | Halozyme, Inc. (San Diego, CA) | 2031-12-30 | search | ||
| Baxalta Incorporated | FEIBA | anti-inhibitor coagulant complex | KIT | 101447 | 1 | 1986-01-31 | 8,822,638 | Baxter International Inc. (Deerfield, IL) Baxter Healthcare SA (Glattpark (Opfikon), CH) | 2028-04-17 | search | ||
| Baxalta Incorporated | FEIBA | anti-inhibitor coagulant complex | KIT | 101447 | 1 | 1986-01-31 | 8,697,747 | THe UAB Research Foundation (Birmingham, AL) | 2029-03-05 | search | ||
| Baxalta Incorporated | FEIBA | anti-inhibitor coagulant complex | KIT | 101447 | 1 | 1986-01-31 | 8,563,688 | Baxter International Inc. (Deerfield, IL) Baxter Healthcare SA (Glattpark (Opfikon), CH) | 2028-04-17 | search | ||
| Baxalta Incorporated | FEIBA | anti-inhibitor coagulant complex | KIT | 101447 | 1 | 1986-01-31 | 8,455,439 | Portola Pharmaceuticals, Inc. (South San Francisco, CA) | 2028-11-14 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
